Exagen Inc.
XGNNasdaqCIK 1274737HealthcareFiscal year ends Dec 31
Reports and events: 122 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0413:15 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001274737-26-000048 |
| 2026-08-0412:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001274737-26-000047 |
| 2026-06-0920:14 ET | 8-K | 5.07 Shareholder vote results | 0001274737-26-000033 |
| 2026-05-1113:17 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001274737-26-000029 |
| 2026-05-1112:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001274737-26-000027 |
| 2026-04-2721:17 ET | DEF 14A | Proxy statementPeriod 2026-06-09 | 0001274737-26-000020 |
| 2026-04-2320:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001274737-26-000015 |
| 2026-03-1013:22 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001274737-26-000009 |
| 2026-03-1012:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001274737-26-000007 |
| 2026-01-1214:03 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001274737-26-000003 |
| 2025-11-0414:16 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001274737-25-000071 |
| 2025-11-0413:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001274737-25-000069 |
| 2025-07-2913:22 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001274737-25-000063 |
| 2025-07-2912:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001274737-25-000061 |
| 2025-07-1720:33 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001274737-25-000055 |
| 2025-06-1120:49 ET | 8-K | 5.07 Shareholder vote results | 0001274737-25-000036 |
| 2025-05-0920:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-116881 |
| 2025-05-0820:06 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-115946 |
| 2025-05-0513:31 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001274737-25-000026 |
| 2025-05-0512:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001274737-25-000023 |
| 2025-04-3010:15 ET | DEF 14A | Proxy statementPeriod 2025-06-10 | 0001193125-25-105576 |
| 2025-04-2820:05 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-100447 |
| 2025-03-1113:21 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001274737-25-000019 |
| 2025-03-1112:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001274737-25-000018 |
| 2025-01-1313:00 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001274737-25-000003 |
| 2024-11-1214:15 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001274737-24-000092 |
| 2024-11-1213:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001274737-24-000091 |
| 2024-08-0513:15 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001274737-24-000079 |
| 2024-08-0512:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001274737-24-000078 |
| 2024-08-0221:20 ET | 8-K/A | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001274737-24-000074 |
| 2024-08-0212:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001274737-24-000071 |
| 2024-06-1120:08 ET | 8-K | 5.07 Shareholder vote results | 0001274737-24-000056 |
| 2024-05-1313:27 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001274737-24-000048 |
| 2024-05-1312:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001274737-24-000045 |
| 2024-04-2612:32 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001274737-24-000030 |
| 2024-04-2612:31 ET | DEF 14A | Proxy statementPeriod 2023-12-31 | 0001274737-24-000028 |
| 2024-03-1813:26 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001274737-24-000022 |
| 2024-03-1812:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001274737-24-000019 |
| 2024-01-0813:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001274737-24-000006 |
| 2023-12-1121:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001274737-23-000116 |
| 2023-11-1721:30 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001274737-23-000105 |
| 2023-11-1322:24 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001274737-23-000103 |
| 2023-11-1321:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001274737-23-000101 |
| 2023-10-2620:05 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001274737-23-000096 |
| 2023-08-0713:23 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001274737-23-000088 |
| 2023-08-0712:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001274737-23-000085 |
| 2023-07-2420:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001274737-23-000074 |
| 2023-06-1420:50 ET | 8-K | 5.07 Shareholder vote results | 0001274737-23-000067 |
| 2023-05-1521:16 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001274737-23-000049 |
| 2023-05-1520:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001274737-23-000046 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:10 ET. Listed shows no prices and gives no investment advice.